283 related articles for article (PubMed ID: 22228937)
1. Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.
Baikar S; Malpathak N
Pharmacogn Rev; 2010 Jan; 4(7):12-26. PubMed ID: 22228937
[TBL] [Abstract][Full Text] [Related]
2. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
[TBL] [Abstract][Full Text] [Related]
3. Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.
Jain CK; Majumder HK; Roychoudhury S
Curr Genomics; 2017 Feb; 18(1):75-92. PubMed ID: 28503091
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic.
Holden JA
Curr Med Chem Anticancer Agents; 2001 May; 1(1):1-25. PubMed ID: 12678768
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.
Liang X; Wu Q; Luan S; Yin Z; He C; Yin L; Zou Y; Yuan Z; Li L; Song X; He M; Lv C; Zhang W
Eur J Med Chem; 2019 Jun; 171():129-168. PubMed ID: 30917303
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
7. DNA topoisomerases as targets for anticancer drugs.
Topcu Z
J Clin Pharm Ther; 2001 Dec; 26(6):405-16. PubMed ID: 11722677
[TBL] [Abstract][Full Text] [Related]
8. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
9. Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
Baglini E; Salerno S; Barresi E; Robello M; Da Settimo F; Taliani S; Marini AM
Eur J Pharm Sci; 2021 Jan; 156():105594. PubMed ID: 33059042
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs.
Shen LL; Baranowski J; Fostel J; Montgomery DA; Lartey PA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2778-84. PubMed ID: 1336349
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase as target for antibacterial and anticancer drug discovery.
Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
[TBL] [Abstract][Full Text] [Related]
12. Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2018; 19(3):238-274. PubMed ID: 28059043
[TBL] [Abstract][Full Text] [Related]
13. Bioassays and In Silico Methods in the Identification of Human DNA Topoisomerase IIα Inhibitors.
Bergant K; Janezic M; Perdih A
Curr Med Chem; 2018; 25(28):3286-3318. PubMed ID: 29508675
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase I poisons and suppressors as anticancer drugs.
Bailly C
Curr Med Chem; 2000 Jan; 7(1):39-58. PubMed ID: 10637356
[TBL] [Abstract][Full Text] [Related]
15. Recent developments of DNA poisons--human DNA topoisomerase IIα inhibitors--as anticancer agents.
Pogorelčnik B; Perdih A; Solmajer T
Curr Pharm Des; 2013; 19(13):2474-88. PubMed ID: 23363399
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity.
Mordente A; Meucci E; Martorana GE; Tavian D; Silvestrini A
Curr Med Chem; 2017; 24(15):1607-1626. PubMed ID: 27978799
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage.
Riou JF; Gabillot M; Philippe M; Schrevel J; Riou G
Biochemistry; 1986 Apr; 25(7):1471-9. PubMed ID: 3011062
[TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerases in therapy--tenth conference. 6-8 October 1999, Amsterdam, The Netherlands.
Boege F
IDrugs; 1999 Dec; 2(12):1275-7. PubMed ID: 16113955
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase I and II Inhibitors: A Patent Review.
Singh A; Kaur N; Singh G; Sharma P; Bedi P; Sharma S; Nepali K
Recent Pat Anticancer Drug Discov; 2016; 11(4):401-423. PubMed ID: 27450102
[TBL] [Abstract][Full Text] [Related]
20. Natural Product Inhibitors of Topoisomerases: Review and Docking Study.
Scotti L; Bezerra Mendonca FJ; Ribeiro FF; Tavares JF; da Silva MS; Barbosa Filho JM; Scotti MT
Curr Protein Pept Sci; 2018; 19(3):275-291. PubMed ID: 28079013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
